Incyte (INCY) Other Operating Expenses (2010 - 2026)

Incyte has reported Other Operating Expenses for 17 years, with the latest figure at $127.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 50.51% year-over-year to $127.6 million; the trailing twelve-month figure through Mar 2026 stood at $369.8 million (up 336.31% YoY), and the FY2025 full-year result was $242.3 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $127.6 million, down from $242.3 million in the prior quarter.
• The five-year high for Other Operating Expenses was $242.3 million in Q2 2025, with the low at $34.5 million in Q3 2022.
• Historically, Other Operating Expenses has averaged $86.1 million across 5 years, with a median of $68.9 million in 2023.
• Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 33.64% — and 2023, when it jumped 76.2%.
• Incyte's Other Operating Expenses stood at $82.4 million in 2022, then rose by 13.24% to $93.3 million in 2023, then sank by 36.28% to $59.5 million in 2024, then surged by 307.32% to $242.3 million in 2025, then plunged by 47.34% to $127.6 million in 2026.
• The last three Other Operating Expenses figures came in at $127.6 million (Q1 2026), $242.3 million (Q2 2025), and $84.8 million (Q1 2025), per Business Quant data.